Literature DB >> 33276149

Effect of mixed strain infections on clinical and epidemiological features of tuberculosis in Florida.

Michael Asare-Baah1, Marie Nancy Séraphin2, LaTweika A T Salmon3, Michael Lauzardo2.   

Abstract

Mixed infections with genetically distinct Mycobacterium tuberculosis (MTB) strains within a single host have been documented in different settings; however, this phenomenon is rarely considered in the management and care of new and relapse tuberculosis (T.B.) cases. This study aims to establish the epidemiological and clinical features of mixed infections among culture-confirmed T.B. patients enrolled in tuberculosis care at the Florida Department of Health (FDOH) and measure its association with T.B. mortality. We analyzed de-identified surveillance data of T.B. cases enrolled in T.B. care from April 2008 to January 2018. Mixed MTB infection was determined by the presence of more than one Copy Number Variant (CNV) in at least one locus, based on the genotype profile pattern of at least one isolate using 24-locus Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat (MIRU-VNTR). The prevalence of mixed MTB infections among the 4944 culture-confirmed TB cases included in this analysis was 2.6% (129). Increased odds of mixed infections were observed among middle-aged patients, 45-64 years (AOR = 2.38; 95% CI: 0.99, 5.69; p = 0.0513), older adults 65 years and above (AOR = 3.95; 95% CI: 1.63, 9.58; p = 0.0023) and patients with diabetes (OR = 1.77; 95% CI: 1.12, 2.80; p = 0.0150). There was no significant association between mixed infections and death. Our study provides insight into the epidemiological and clinical characteristics of patients with mixed MTB infections, which is essential in the management of T.B. patients. Published by Elsevier B.V.

Entities:  

Keywords:  MIRU-VNTR; Mixed-infections; Mycobacterium tuberculosis; T.B. mortality

Mesh:

Substances:

Year:  2020        PMID: 33276149      PMCID: PMC7855629          DOI: 10.1016/j.meegid.2020.104659

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  40 in total

1.  Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa.

Authors:  Ted Cohen; Douglas Wilson; Kristina Wallengren; Elizabeth Y Samuel; Megan Murray
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

2.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

3.  Prediction of the hidden genotype of mixed infection strains in Iranian tuberculosis patients.

Authors:  Mansour Kargarpour Kamakoli; Ghazaleh Farmanfarmaei; Morteza Masoumi; Sharareh Khanipour; Safoora Gharibzadeh; Christophe Sola; Abolfazl Fateh; Seyed Davar Siadat; Guislaine Refregier; Farzam Vaziri
Journal:  Int J Infect Dis       Date:  2020-04-03       Impact factor: 3.623

4.  Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype.

Authors:  Manish Pareek; Jason Evans; John Innes; Grace Smith; Suzie Hingley-Wilson; Kathryn E Lougheed; Saranya Sridhar; Martin Dedicoat; Peter Hawkey; Ajit Lalvani
Journal:  Thorax       Date:  2012-09-27       Impact factor: 9.139

5.  Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda.

Authors:  Katherine R Dickman; Lydia Nabyonga; David P Kateete; Fred A Katabazi; Benon B Asiimwe; Harriet K Mayanja; Alphonse Okwera; Christopher Whalen; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2010-12-10       Impact factor: 3.090

Review 6.  Mixed infections in tuberculosis: The missing part in a puzzle.

Authors:  Samira Tarashi; Abolfazl Fateh; Mehdi Mirsaeidi; Seyed Davar Siadat; Farzam Vaziri
Journal:  Tuberculosis (Edinb)       Date:  2017-09-15       Impact factor: 3.131

7.  ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections.

Authors:  Leonid Chindelevitch; Caroline Colijn; Prashini Moodley; Douglas Wilson; Ted Cohen
Journal:  PLoS Comput Biol       Date:  2016-02-01       Impact factor: 4.475

8.  Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.

Authors:  Matthias Merker; Camille Blin; Stefano Mona; Nicolas Duforet-Frebourg; Sophie Lecher; Eve Willery; Michael G B Blum; Sabine Rüsch-Gerdes; Igor Mokrousov; Eman Aleksic; Caroline Allix-Béguec; Annick Antierens; Ewa Augustynowicz-Kopeć; Marie Ballif; Francesca Barletta; Hans Peter Beck; Clifton E Barry; Maryline Bonnet; Emanuele Borroni; Isolina Campos-Herrero; Daniela Cirillo; Helen Cox; Suzanne Crowe; Valeriu Crudu; Roland Diel; Francis Drobniewski; Maryse Fauville-Dufaux; Sébastien Gagneux; Solomon Ghebremichael; Madeleine Hanekom; Sven Hoffner; Wei-wei Jiao; Stobdan Kalon; Thomas A Kohl; Irina Kontsevaya; Troels Lillebæk; Shinji Maeda; Vladyslav Nikolayevskyy; Michael Rasmussen; Nalin Rastogi; Sofia Samper; Elisabeth Sanchez-Padilla; Branislava Savic; Isdore Chola Shamputa; Adong Shen; Li-Hwei Sng; Petras Stakenas; Kadri Toit; Francis Varaine; Dragana Vukovic; Céline Wahl; Robin Warren; Philip Supply; Stefan Niemann; Thierry Wirth
Journal:  Nat Genet       Date:  2015-01-19       Impact factor: 38.330

9.  Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia.

Authors:  Isdore C Shamputa; Levan Jugheli; Nikoloz Sadradze; Eve Willery; Françoise Portaels; Philip Supply; Leen Rigouts
Journal:  Respir Res       Date:  2006-07-17

Review 10.  Co-evolution of Mycobacterium tuberculosis and Homo sapiens.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

View more
  1 in total

1.  Mixed tuberculosis infections in Northwest of Iran.

Authors:  Mohammad Asgharzadeh; Zahra Taghinejad; Behroz Mahdavipoor; Vahid Asgharzadeh; Hossein Samadi Kafil; Jalil Rashedi
Journal:  Infez Med       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.